Serial Number 79366711
Registration 7646314
700

Registration Progress

Application Filed
Mar 6, 2023
Under Examination
Approved for Publication
Nov 26, 2024
Published for Opposition
Nov 26, 2024
Registered
Jan 14, 2025

Trademark Image

Basic Information

Serial Number
79366711
Registration Number
7646314
Filing Date
March 6, 2023
Registration Date
January 14, 2025
Published for Opposition
November 26, 2024
Drawing Code
2

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 14, 2025
Registration
Registered
Classes
005 010 042

Rights Holder

Calliditas Therapeutics AB

99
Address
Calliditas Therapeutics AB,
PO Box 70351 SE-107 24 Stockholm
SE

Ownership History

Calliditas Therapeutics AB

Original Applicant
99
SE

Calliditas Therapeutics AB

Owner at Publication
99
SE

Calliditas Therapeutics AB

Original Registrant
99
SE

Legal Representation

Attorney
Karen Lim

USPTO Deadlines

Next Deadline
2009 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-01-14)
Due Date
January 14, 2031
Grace Period Ends
July 14, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

28 events
Date Code Type Description Documents
Apr 14, 2025 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Jan 14, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jan 14, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 26, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 26, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 20, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 4, 2024 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Nov 4, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 4, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 4, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 14, 2024 CNFR R FINAL REFUSAL WRITTEN Loading...
Aug 14, 2024 GNFR O FINAL REFUSAL E-MAILED Loading...
Aug 14, 2024 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Jul 22, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 22, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 22, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 11, 2024 CORR I CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED Loading...
May 20, 2024 CRCV M CORRECTION TRANSACTION RECEIVED FROM IB Loading...
Feb 14, 2024 RFNT P REFUSAL PROCESSED BY IB Loading...
Jan 24, 2024 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Jan 24, 2024 RFRR P REFUSAL PROCESSED BY MPU Loading...
Jan 9, 2024 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Jan 8, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 4, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 24, 2023 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Apr 7, 2023 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Apr 3, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 31, 2023 SDRC M SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceuticals, medical and veterinary preparations in the nature of preparations for the treatment of kidney diseases, autoimmune diseases, Berger's disease, bowel diseases, liver diseases and immune system diseases; sanitary preparations for medical purposes; dietetic food and nutritive substances for micro-organisms adapted for medical or veterinary use, food for babies; dietary supplements for human beings and animals; Surgical plasters, materials for dressings, namely, surgical dressings; diagnostic preparations for medical use; anti-inflammatories; pharmaceutical preparations and substances for the treatment of kidney and liver diseases, inflammatory diseases and immune system related diseases and disorders; corticosteroid drugs for medical use; medicinal preparations for treating kidney diseases, autoimmune diseases, Berger's disease, bowel diseases, liver diseases and immune system diseases
Class 010
Surgical apparatus and instruments for medical, dental and veterinary purposes; artificial limbs, eyes and teeth; orthopaedic bandages; suture materials; medical apparatus, namely, an extremity garment donning assist device for use by physically disabled persons; pharmaceutical instruments and apparatus for administering pharmaceuticals, namely, injection device for pharmaceuticals; ultrasonic medical diagnostic instruments; medical clothing specifically for operating rooms
Class 042
Scientific and technological services namely, medical research and design relating thereto; industrial pharmaceutical analysis, industrial pharmaceutical research and industrial pharmaceutical design services; quality control and authentication services in the field of pharmaceuticals; medical and pharmacological research services; scientific laboratory services; research and development of pharmaceutical products and medicines; scientific and technological research consultancy services; design, development and testing of pharmaceuticals; information, advisory and technological consultancy services in relation to the aforesaid services

Additional Information

Design Mark
The mark consists of an abstract ribbon design in the shape of a kidney that is gold on the outside and purple on the inside.
Color Claim
The color(s) colors gold and purple is/are claimed as a feature of the mark.

Classification

International Classes
005 010 042